California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
California is moving ahead with its plan to produce state-sponsored insulin, but its goal of offering cheaper medicine than brand-name companies may be much harder to achieve now that those major drug makers have decided to significantly drop sticker prices on some products. So while some experts welcomed the news last weekend that the state…